Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Testing revenue418.96M93.99%
Product revenue13.65M3.06%
Biopharmaceutical and other revenue13.15M2.95%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States423.54M95.01%
International22.23M4.99%